Evidence map›Paper›PMID 41554314›Full record

ArticleMetabolic engineering2026

Genome minimization of a Burkholderia bacterial host.

Bruno S Paulo, Sean B Romanowski, Adjo E Kadjo, Vitor B Lourenzon, Alessandra S Eustáquio

Abstract read
In one paragraph

Article in Metabolic engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bruno S PauloDepartment of Pharmaceutical Sciences and Center for Biomolecular Sciences, Retzky College of Pharmacy, University of Illinois Chicago, Chicago, IL, USA.
Sean B RomanowskiDepartment of Pharmaceutical Sciences and Center for Biomolecular Sciences, Retzky College of Pharmacy, University of Illinois Chicago, Chicago, IL, USA.
Adjo E KadjoDepartment of Pharmaceutical Sciences and Center for Biomolecular Sciences, Retzky College of Pharmacy, University of Illinois Chicago, Chicago, IL, USA.
Vitor B LourenzonDepartment of Pharmaceutical Sciences and Center for Biomolecular Sciences, Retzky College of Pharmacy, University of Illinois Chicago, Chicago, IL, USA.
Alessandra S EustáquioDepartment of Pharmaceutical Sciences and Center for Biomolecular Sciences, Retzky College of Pharmacy, University of Illinois Chicago, Chicago, IL, USA. Electronic address: ase@uic.edu.

Funding

Research Training in Natural Product Complementary and Integrative HealthT32AT007533 · NCCIH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Joanna E Burdette, JIMMY ORJALA · 2013 to 2026
$4.3M
Development of a Bacterial Host for Natural Product Discovery and ProductionR01GM129344 · NIGMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI EUSTAQUIO, ALESSANDRA S · 2020 to 2023
$1.5M
NCCIH NIH HHS T32 AT007533NIGMS NIH HHS R01 GM129344
6 · The paper itself

Abstract

Genome minimization, including the deletion of endogenous gene clusters that encode natural products, is a common strategy to improve the yield of heterologous products. We have been interested in developing Burkholderia sp. FERM BP-3421 as an alternative bacterial host. Instead of indiscriminately deleting gene clusters, which may have deleterious effects, we guided our efforts using transcriptomics data from production cultures. The genome of FERM BP-3421 is subdivided into two chromosomes and two plasmids. The top transcribed gene clusters were those encoding polyketide-nonribosomal peptide spliceostatins on plasmid p1 and nonribosomal peptide selethramide on chromosome 1. Deletion of the spliceostatin cluster had been shown to improve titers of the ribosomal peptide capistruin, whereas we showed that deletion of the selethramide cluster had no effect on capistruin titers. We next targeted the two endogenous plasmids using a CRISPR-Cas12a strategy, resulting in an 11 % reduction in genome size. The plasmid cured strains showed improved growth and 20-40 % increased production of capistruin depending on whether one or both plasmids were deleted. However, deletion of p2 alone negatively affected the heterologous production of two distinct polyketide-nonribosomal peptides. The p2

Indexed as

BurkholderiaCRISPR-Cas SystemsGenome, BacterialMetabolic EngineeringMultigene FamilyBacterial host developmentCRISPR-Cas12aGenome minimizationHeterologous expressionNatural productsTranscriptomics

Identifiers

PMID41554314
PMCPMC12969996

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.